ATE287958T1 - Verbesserte krebstherapie - Google Patents

Verbesserte krebstherapie

Info

Publication number
ATE287958T1
ATE287958T1 AT94931658T AT94931658T ATE287958T1 AT E287958 T1 ATE287958 T1 AT E287958T1 AT 94931658 T AT94931658 T AT 94931658T AT 94931658 T AT94931658 T AT 94931658T AT E287958 T1 ATE287958 T1 AT E287958T1
Authority
AT
Austria
Prior art keywords
cells
animal
nitroreductase
human
cancerous
Prior art date
Application number
AT94931658T
Other languages
English (en)
Inventor
Thomas Connors
Richard Knox
Roger Sherwood
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Application granted granted Critical
Publication of ATE287958T1 publication Critical patent/ATE287958T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT94931658T 1993-11-05 1994-11-04 Verbesserte krebstherapie ATE287958T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939323008A GB9323008D0 (en) 1993-11-05 1993-11-05 Improvements relating to cancer therapy
PCT/GB1994/002423 WO1995012678A2 (en) 1993-11-05 1994-11-04 Improvements relating to cancer therapy

Publications (1)

Publication Number Publication Date
ATE287958T1 true ATE287958T1 (de) 2005-02-15

Family

ID=10744825

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94931658T ATE287958T1 (de) 1993-11-05 1994-11-04 Verbesserte krebstherapie

Country Status (11)

Country Link
US (1) US5958682A (de)
EP (1) EP0725826B1 (de)
JP (1) JP3867211B2 (de)
AT (1) ATE287958T1 (de)
AU (1) AU690935B2 (de)
CA (1) CA2175687C (de)
DE (1) DE69434244T2 (de)
ES (1) ES2237754T3 (de)
GB (1) GB9323008D0 (de)
NZ (1) NZ275147A (de)
WO (1) WO1995012678A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9402857D0 (en) 1994-02-15 1994-04-06 Isis Innovation Targeting gene therapy
US6451571B1 (en) 1994-05-02 2002-09-17 University Of Washington Thymidine kinase mutants
US5877010A (en) * 1994-05-02 1999-03-02 University Of Washington Thymidine kinase mutants
GB9422264D0 (en) * 1994-11-04 1994-12-21 Cancer Res Campaign Tech Inducible cell ablation
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
GB9517001D0 (en) * 1995-08-18 1995-10-18 Denny William Enediyne compounds
US6130237A (en) * 1996-09-12 2000-10-10 Cancer Research Campaign Technology Limited Condensed N-aclyindoles as antitumor agents
GB9709421D0 (en) 1997-05-10 1997-07-02 Zeneca Ltd Chemical compounds
GB9712370D0 (en) * 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
IL137164A0 (en) 1998-01-23 2001-07-24 Newbiotics Inc Enzyme catalyzed therapeutic agents
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
GB9819472D0 (en) 1998-09-07 1998-10-28 Cancer Soc Auckland Div Nz Inc Novel nitrophenylaziridine compounds and their use as prodrugs
GB9903019D0 (en) * 1999-02-10 1999-03-31 Microbiological Res Authority Nitroreductase enzymes
MXPA02000762A (es) 1999-07-22 2002-08-20 Newbiotics Inc Metodos para tratar tumores resistentes a terapia.
CN1391487A (zh) * 1999-07-22 2003-01-15 新生物公司 酶催化的抗一感染治疗剂
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
US6656718B2 (en) 2000-07-07 2003-12-02 Cancer Research Technology Limited Modified carboxypeptidase enzymes and their use
US10357577B2 (en) 2010-07-16 2019-07-23 Auckland Uniservices Limited Bacterial nitroreductase enzymes and methods relating thereto
LT7046B (lt) 2022-04-15 2024-02-12 Vilniaus Universitetas Hidrolazės ir jų panaudojimas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804068D0 (en) * 1988-02-22 1988-03-23 Roberts J R Improvements relating to control of neoplastic tissue growth
US5633158A (en) * 1991-10-23 1997-05-27 Cancer Research Campaign Technology Limited Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form
NZ240785A (en) * 1991-11-28 1995-08-28 Cancer Res Campaign Tech Substituted nitro aniline derivatives and medicaments

Also Published As

Publication number Publication date
WO1995012678A3 (en) 1995-06-15
AU690935B2 (en) 1998-05-07
JP3867211B2 (ja) 2007-01-10
DE69434244T2 (de) 2005-12-29
CA2175687C (en) 2006-05-09
AU8065794A (en) 1995-05-23
WO1995012678A2 (en) 1995-05-11
ES2237754T3 (es) 2005-08-01
EP0725826B1 (de) 2005-01-26
CA2175687A1 (en) 1995-05-11
DE69434244D1 (de) 2005-03-03
US5958682A (en) 1999-09-28
JPH09505037A (ja) 1997-05-20
GB9323008D0 (en) 1994-01-05
NZ275147A (en) 1997-11-24
EP0725826A1 (de) 1996-08-14

Similar Documents

Publication Publication Date Title
DE69434244D1 (de) Verbesserte krebstherapie
AU2003285863A1 (en) Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
RU94045155A (ru) Способы ингибирования болезни альцгеймера
IL133585A0 (en) Soluble prodrugs of paclitaxel
ATE246513T1 (de) Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
AU3040995A (en) Treatment of autoimmune diseases by oral administration of autoantigens
ATE200733T1 (de) Pharmazeutische zubereitungen, die fluoxetin enthalten
ATE197670T1 (de) Parenterales busulfan zur behandlung von malignen krankheiten
AU688101B2 (en) Live vaccine for the treatment of tumour diseases
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
CA2284079A1 (en) Immunotoxins and methods of inducing immune tolerance
HUT64569A (en) A process for preparing polypeptide-type compounds usefules for medical treatment of the human body
SI0841912T1 (en) Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines
WO1996032137A3 (en) Methods of inducing immune tolerance using immunotoxins
BR0111024A (pt) Composições e métodos para a terapia e diagnóstico de câncer de mama
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
MXPA05010804A (es) Torio 227 para uso en radioterapia de enfermedades del tejido blando.
DK0697875T3 (da) Anvendelse af modificerede TALL-104 celler til behandling af cancer og virale sygdomme
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
JP2004507469A5 (de)
MX9708615A (es) Terapia de genes animales.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties